Navigation Links
'Disappearing Stent is a Dream Come True' - World Leaders at India Live Cardiology Conference 2013
Date:3/7/2013

CHENNAI, March 7, 2013 /PRNewswire/ --

For its ability to unblock and then make arteries return to natural form, the recently launched bioresorbable vascular scaffold (BVS and also known as disappearing stent) is being hailed as the 4th revolution in management of coronary artery disease at India's biggest conference on interventional cardiology that took place at Hotel ITC Grand Chola, Chennai from February 27 to March 2, 2013.

Dr. Samin K. Sharma , Director, Clinical & Interventional Cardiology, Mount Sinai Medical Center, New York said, "If BVS is used in the treatment of coronary artery disease, the long term benefits are huge. Since the stent will leave body after 2 years after doing its work of clearing blockages, patient will not have to take blood thinning medicines lifelong and the vessels can return to its natural form making it work as per body needs. It is nothing less than a dream come true."

According to Dr. Mathew Samuel , father of Angioplasty, and Dr. Antonio Colombo , famously known as world leader in interventional cardiology from Italy, angioplasty with conventional stents has always carried the fear of clot because of stent called late stent thrombosis.

This is seen in about 10% of patients after 1 or 2 years. This problem is expected to be less if BVS is used.

"Unlike western world, the prevalence of heart disease is significantly high among young people in India. For these people, the dissolving stent is a blessing as they will no longer have to worry about any alteration in natural artery structure in their long life ahead," added Dr. Sharma

BVS or Absorb is a first-of-its-kind device for the treatment of coronary artery disease (CAD). It works by restoring b
'/>"/>

SOURCE India Live Cardiology
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
2. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
3. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
4. Medicare Policies Are Inconsistent with Cost-Effective Aging-at-Home Strategies
5. Murray Dental Laboratory Deploys Jensen Dental CAD/CAM Solution for Increased Productivity, Higher Sales and More Consistent Restorations
6. Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
7. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
8. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
9. Terumo Completes U.S. Patient Enrollment in the OSPREY Trial to Evaluate the MISAGO Self-expanding Stent
10. Global Drug-Eluting Stents Industry
11. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... available in its catalogue: ... for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
(Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
(Date:4/17/2014)... 2014) Two recent papers by a University ... may help scientists develop treatments or vaccines for ... encephalitis and other disease-causing flaviviruses. , Jeffrey S. ... genetics at the School of Medicine and an ... Institute, and colleagues recently published articles in the ...
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
(Date:4/17/2014)... Medicine (BUSM) have discovered that the anti-seizure drug ... The findings, reported in the American Journal ... to more effective treatments for alcoholism. , Excessive ... causes of illness and death in the U.S. ... the productivity of workers and necessitating huge health ...
(Date:4/17/2014)... and their partners have found that their proprietary microbicide ... of multiple sexually transmitted infections (STIs) in both the ... 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded study ... effective against multiple strains of HIV, and has a ... viruses of at least eight hours prior to exposure. ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... 02 April 2011: Exciting new data presented today at ... in chronic hepatitis C (HCV) patients suppressed the emergence ... of sustained virological response - undetectable HCV RNA - ... therapy study, HCV patients were given four drugs in ...
... compounds that inhibit two of the most frequently mutated ... I trial, according to data presented at the AACR ... The research, presented by Johanna Bendell, M.D., tests ... which inhibits PI3K. Bendell, director of Gastrointestinal Oncology ...
... , FRIDAY, April 1 (HealthDay News) -- Updated ... go to camp were released this week by the American ... should consider their child,s interests, skills and overall well-being, to ... Parents also need to medically and mentally prepare their ...
... of Pennsylvania School of Medicine have determined that a ... association with one of the biological processes associated with ... in the latest issue of Nature Communications. ... proteins associated with a suite of neurodegenerative diseases. Tau ...
... , FRIDAY, April 1 (HealthDay News) -- Ballet ... put tremendous strain on certain parts of the body, so ... the American Academy of Orthopaedic Surgeons. "When it comes ... but the fact of the matter is that ballet is ...
... -- An award-winning Loyola University Health System study ... of smoke-inhalation patients., Contrary to expectations, patients who ... in their lungs than patients who survived., "Perhaps ... dysfunction will allow for therapies that further improve ...
Cached Medicine News:Health News:Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment 2Health News:Combining MEK and PI3K inhibitors appears encouraging in a safety study with early signs of anti-tumor activity 2Health News:Pediatrics Group Offers Guidelines to Keep Young Campers Safe, Healthy 2Health News:Penn study suggests another avenue for detecting Alzheimer's disease 2Health News:Rigors of Ballet Require Careful Training 2Health News:Surprising finding from smoke inhalation study 2
... Trio with Tim™ (Total imaging matrix) ... speed, and highest resolution at 3T. ... 16, advanced applications can now be ... Trio with Tim is an excellent ...
... It enables you to scan every beating ... lowest radiation dose possible. A scanner using ... same time. It provides one-stop diagnosis in acute ... and heart rate. Combined with the Cardiac Engine, ...
... Medical Billing Assistant (MBA) is ... billing and practice management software ... Microsoft SQL Server technology and ... capabilities and account receivable management, ...
VisiClaim allows you to create, submit, track and manage your claims and reimbursements. VisiClaim gives you control over managing your claims and your billing....
Medicine Products: